| First Author | El Hakam C | Year | 2022 |
| Journal | Genes (Basel) | Volume | 13 |
| Issue | 8 | PubMed ID | 36011266 |
| Mgi Jnum | J:335128 | Mgi Id | MGI:7380464 |
| Doi | 10.3390/genes13081356 | Citation | El Hakam C, et al. (2022) PHEX(L222P) Mutation Increases Phex Expression in a New ENU Mouse Model for XLH Disease. Genes (Basel) 13(8) |
| abstractText | Phex(L222P) mouse is a new ENU mouse model for XLH disease due to Leu to Pro amino acid modification at position 222. Phex(L222P) mouse is characterized by growth retardation, hypophosphatemia, hypocalcemia, reduced body bone length, and increased epiphyseal growth plate thickness and femur diameter despite the increase in PHEX(L222P) expression. Actually, Phex(L222P) mice show an increase in Fgf23, Dmp1, and Mepe and Slc34a1 (Na-Pi IIa cotransporter) mRNA expression similar to those observed in Hyp mice. Femoral osteocalcin and sclerostin and Slc34a1 do not show any significant variation in Phex(L222P) mice. Molecular dynamics simulations support the experimental data. P222 might locally break the E217-Q224 beta-sheet, which in turn might disrupt inter-beta-sheet interactions. We can thus expect local protein misfolding, which might be responsible for the experimentally observed PHEX(L222P) loss of function. This model could be a valuable addition to the existing XLH model for further comprehension of the disease occurrence and testing of new therapies. |
